Colin Sandercock, SVP, General Counsel and Secretary at Cue Biopharma, Inc. (CUE), bought 30,150 shares at $7.90 ($238K) on 2019-06-10, disclosed to the SEC on 2020-02-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.35 | 100 | $735 | 0.3% |
| 2 | $7.90 | 15,025 | $119K | 49.8% |
| 3 | $7.90 | 15,025 | $119K | 49.8% |
| Total | $7.90 avg | 30,150 | $238K | 100% |
| Filing → |
| CUE | BUY | 2019-06-10 | $133K | — | Filing → |